4//SEC Filing
Frapaise Francois-Xavier 4
Accession 0001142576-10-000009
CIK 0001142576other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 2:14 PM ET
Size
5.8 KB
Accession
0001142576-10-000009
Insider Transaction Report
Form 4
Frapaise Francois-Xavier
SVP, Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2010-01-08+30,000→ 30,000 totalExercise: $11.85Exp: 2020-01-08→ Common stock (30,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/48 of the shares shall vest each month thereafter, subject to optionee continuing to be a service provider on each such date.
Documents
Issuer
OPTIMER PHARMACEUTICALS INC
CIK 0001142576
Entity typeother
Related Parties
1- filerCIK 0001455044
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 2:14 PM ET
- Size
- 5.8 KB